Max Robotics — Global Service Robot Directory + US Certification

About

Andreas Stensvold is a clinical researcher whose work focuses on the quality of life and adverse effects experienced by prostate cancer patients following curative treatment. His primary research areas include the long-term bothersome side effects of surgery and radiotherapy, the methodological approaches for accurately measuring these patient-reported outcomes, and the real-world application of clinical guidelines in oncology. Stensvold’s major contribution lies in advancing how we study and interpret treatment-related morbidity. He has been instrumental in applying and comparing novel statistical methods—such as the proportion of patients regaining 90% of baseline function (PBS-90) and Generalized Estimating Equations (GEE)—to better capture the trajectory and impact of sexual, urinary, and bowel dysfunction over time. His most cited work, “Bother problems in prostate cancer patients after curative treatment” (30 citations), highlights the critical distinction between functional loss and the patient’s subjective distress, a nuance often overlooked in clinical practice. Additionally, his research on clinicians’ adherence to treatment guidelines provides valuable insight into the gap between evidence-based recommendations and actual clinical decision-making. Through his methodical approach, Stensvold has helped shape a more patient-centered understanding of treatment success in prostate cancer care.